BusinessERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-FBy Nasdaq OMXApr 24, 2018, 8:30 PM UTC
BusinessERYTECH to Present Results from Phase I Trial of eryaspase in ALL and New Pre-clinical Data at AACR 2018By Nasdaq OMXApr 12, 2018, 5:30 AM UTC
